| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000156328.28485.AD |
| P698 | PubMed publication ID | 15723982 |
| P50 | author | Steffen E. Petersen | Q42794821 |
| Adrian Banning | Q51540650 | ||
| Keith Channon | Q56420294 | ||
| Jane M Francis | Q95692907 | ||
| Joseph B Selvanayagam | Q117226944 | ||
| P2093 | author name string | Stefan Neubauer | |
| Italo Porto | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1027-1032 | |
| P577 | publication date | 2005-02-21 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging | |
| P478 | volume | 111 |
| Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
| Q55347100 | 2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology. |
| Q30423759 | 2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology |
| Q36971128 | Advances in clinical applications of cardiovascular magnetic resonance imaging |
| Q38114389 | An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization |
| Q42706225 | An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity |
| Q90390265 | Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention |
| Q43505647 | Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis |
| Q34102878 | Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study |
| Q38106499 | Cardiac MRI of acute coronary syndrome |
| Q30468452 | Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review. |
| Q30480205 | Cardiovascular magnetic resonance in the evaluation of heart failure |
| Q33168179 | Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. |
| Q37194107 | Chest pain after percutaneous coronary intervention in patients with stable angina |
| Q82250010 | Closed-chest animal model of chronic coronary artery stenosis. Assessment with magnetic resonance imaging |
| Q36378795 | Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy |
| Q33924170 | Composite outcomes in coronary bypass surgery versus percutaneous intervention |
| Q36457860 | Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside |
| Q41858219 | Coronary artery stenosis |
| Q53233694 | Coronary microembolization causes long-term detrimental effects on regional left ventricular function. |
| Q34276221 | Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High [...] |
| Q39625064 | Disparity between angiographic coronary lesion complexity and lipid core plaques assessed by near-infrared spectroscopy |
| Q91753067 | Does Prior Percutaneous Coronary Intervention Influence the Outcomes of Coronary Artery Bypass Surgery? |
| Q33777150 | Effect of Pretreatment with Omega-3 Supplement on Cardiac Necrosis Markers in Chronic Kidney Disease Patients Undergoing Elective Percutaneous Coronary Intervention. |
| Q45944730 | Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention. |
| Q38863865 | Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention |
| Q53741454 | Effects of Qishen Yiqi Dripping Pills () in Reducing Myocardial Injury and Preserving Microvascular Function in Patients Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study. |
| Q60912594 | Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial |
| Q37664557 | Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study |
| Q43294342 | Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients |
| Q53369836 | Embolization after percutaneous coronary intervention in acute coronary syndrome. Saphenous vein grafts versus native coronary arteries. |
| Q41107826 | Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging. |
| Q33679842 | Heterogeneous microinfarcts caused by coronary microemboli: evaluation with multidetector CT and MR imaging in a swine model. |
| Q37466728 | High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention |
| Q37092447 | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
| Q48360435 | In-hospital 'CODE STEMI' improves door-to-balloon time in patients undergoing primary percutaneous coronary intervention |
| Q36053300 | Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study |
| Q37414864 | Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study. |
| Q38427068 | Ischaemic conditioning: are we there yet? |
| Q37323623 | Lack of consensus in biomarker measurement to diagnose PCI-related myocardial infarction |
| Q30445992 | Late gadolinium-enhanced cardiac magnetic resonance |
| Q37901592 | Lessons from human coronary aspirate |
| Q92918432 | Lipid-Core Plaque Assessed by Near-Infrared Spectroscopy and Procedure Related Microvascular Injury |
| Q45949829 | MRI monitoring of function, perfusion and viability in microembolized moderately ischemic myocardium. |
| Q45278793 | MRI quantification of left ventricular function in microinfarct versus large infarct in swine model |
| Q26824231 | Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies |
| Q44914938 | Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running. |
| Q38192517 | Making sense of high sensitivity troponin assays and their role in clinical care |
| Q42409828 | Measurement and prevention of myocardial injury during percutaneous coronary intervention |
| Q54353507 | Microcirculatory significance of periprocedural myocardial necrosis after percutaneous coronary intervention assessed by the index of microcirculatory resistance. |
| Q46775757 | Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. |
| Q34962673 | Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition |
| Q37187048 | Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. |
| Q36433342 | Myocardial perfusion is impaired in asymptomatic renal and liver transplant recipients: a cardiovascular magnetic resonance study |
| Q54264972 | Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers. |
| Q37626833 | Organ protection by volatile anesthetics in non-coronary artery bypass grafting surgery. |
| Q36867295 | Percutaneous coronary intervention and the no-reflow phenomenon. |
| Q93083886 | Peri-procedural myocardial infarction is all the same? |
| Q34147112 | Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. |
| Q36263844 | Peri-procedural myocardial injury: 2005 update |
| Q22241918 | Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention |
| Q37782048 | Periprocedural Myocardial Infarction: Review and Classification |
| Q38016744 | Periprocedural myocardial enzyme elevation: prognostic implications for current practice |
| Q35798628 | Persistent CT nephrograms following cardiac catheterisation and intervention: initial observations |
| Q35072915 | Positive association of coronary calcium detected by computed tomography coronary angiography with periprocedural myocardial infarction |
| Q42153168 | Preconditioning by isoflurane as a volatile anesthetic in elective coronary artery bypass surgery |
| Q37215585 | Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention |
| Q53084310 | Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. |
| Q38022548 | Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis. |
| Q35954709 | Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention |
| Q54980932 | Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC). |
| Q44800910 | Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention |
| Q46390050 | Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium. |
| Q43242927 | Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patients. |
| Q90235345 | Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention |
| Q39219871 | Remote Ischemic Conditioning in Elective PCI? |
| Q43051143 | Remote ischaemic conditioning in percutaneous coronary intervention: a meta-analysis of randomised trials |
| Q58566940 | Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update |
| Q41127363 | Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging |
| Q82507027 | Risk factors of cardiac troponin T elevation in patients with stable coronary artery disease after elective coronary drug-eluting stent implantation |
| Q104111651 | Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention |
| Q51786603 | Shedding light on intracoronary pathophysiology |
| Q36473852 | Significance of 99mTc-sestamibi myocardial scintigraphy after percutaneous coronary intervention in patients with acute myocardial infarction |
| Q52886547 | Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a). |
| Q26828732 | Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention |
| Q42348666 | Statins before stents: Does an ounce of prevention improve outcomes? |
| Q36721627 | The Effect of High Dose Cilostazol and Rosuvastatin on Periprocedural Myocardial Injury in Patients with Elective Percutaneous Coronary Intervention. |
| Q27014679 | The cardiac magnetic resonance (CMR) approach to assessing myocardial viability |
| Q100307206 | The clinical effect of recombinant human brain natriuretic peptide on asymptomatic peri-procedural myocardial injury after percutaneous transluminal coronary angioplasty |
| Q37719199 | The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary intervention |
| Q36222553 | The impact of repeated marathon running on cardiovascular function in the aging population |
| Q53594790 | The influence of aortic valve calcification on the risk of periprocedural myocardial injury after elective coronary intervention. |
| Q87548200 | The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention |
| Q37892335 | The therapeutic potential of ischemic conditioning: an update |
| Q34295914 | Third universal definition of myocardial infarction |
| Q57314061 | Third universal definition of myocardial infarction |
| Q36653135 | Troponin-positive chest pain with unobstructed coronary arteries: definitive differential diagnosis using cardiac MRI |
| Q58128613 | Usability of cardiac magnetic resonance imaging for procedural myocardial infarction undergoing rotational atherectomy |
Search more.